<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02292043</url>
  </required_header>
  <id_info>
    <org_study_id>wei liu</org_study_id>
    <nct_id>NCT02292043</nct_id>
  </id_info>
  <brief_title>Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction</brief_title>
  <official_title>Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Harbin Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators would evaluate the effects of the novel method, HTEA on cardiac function in
      the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial
      infarction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators would evaluate the effects of the novel method, HTEA on cardiac function in
      the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial
      infarction. The specific index is 6 miniutes walk distance, echocardiography, NYHA, NTproBNP
      level, peripherial WBC, RBC, PLT, Cre, UA, K+, Na+ upon entrance to hospital and 4 weeks
      after HTEA treatment, and 3 months after discharge. The morbidity and re-hospitalization
      would also calculated 3 months after discharge.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Morbidity</measure>
    <time_frame>1 months to 3 months after discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The decreased degree of NT-proBNP higher than 30%</measure>
    <time_frame>3 months after discharge</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>idiopathic dilated cardiomyopathy group</arm_group_label>
    <description>idiopathic dilated cardiomyopathy group treated with HTEA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>post-myocardial infarction group</arm_group_label>
    <description>post-myocardial infarction group treated with TEA</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HTEA</intervention_name>
    <description>HTEA</description>
    <arm_group_label>idiopathic dilated cardiomyopathy group</arm_group_label>
    <arm_group_label>post-myocardial infarction group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        heart failure.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  90 chronic cardiac failure patients in our hospital were selected and divided into two
             groups.

        Exclusion Criteria:

          -  Vavular diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>wei liu</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Harbin Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>wei liu, Ph.D.</last_name>
    <phone>86-18904502999</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>xiaohui ren</last_name>
    <phone>86-451-85552320</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ren Xiaohui</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaohui Ren</last_name>
      <phone>86-85552320</phone>
      <email>renxiaohui2004@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>the first affiliated hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaohui Ren</last_name>
      <phone>86-451-85552320</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2014</study_first_submitted>
  <study_first_submitted_qc>November 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2014</study_first_posted>
  <last_update_submitted>November 12, 2014</last_update_submitted>
  <last_update_submitted_qc>November 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harbin Medical University</investigator_affiliation>
    <investigator_full_name>Wei Liu</investigator_full_name>
    <investigator_title>Prof. Liu</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

